OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
The OncLive Insider app is live!CME Opportunities
Specialty
View MoreBreast CancerLung CancerGastrointestinal CancerGenitourinary CancersOvarian CancerProstate CancerMelanoma & Skin CancerMCLMPNCAR T-cell TherapyChronic Lymphocytic LeukemiaGynecologic OncologyHematologic OncologyImmuno-OncologyMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
PartnersPublications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker ConsortiumSubscribe
  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2025 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • The OncLive Insider app is live!
  • CME Opportunities
SpecialtySee All >
  • Breast Cancer
  • Lung Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Ovarian Cancer
  • Prostate Cancer
  • Melanoma & Skin Cancer
  • MCL
  • MPN
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gynecologic Oncology
  • Hematologic Oncology
  • Immuno-Oncology
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Precision Medicine: A New Frontier for Advanced Cholangiocarcinoma

EP. 1: Diagnosing CCA

October 21st 2019

EP. 2: Heterogeneity of CCA

October 21st 2019

EP. 3: Tumor Markers in CCA

October 21st 2019

EP. 4: Prevalence of CCA

October 21st 2019

EP. 5: Adjuvant Chemotherapy for CCA

October 21st 2019

EP. 6: Radiation Therapy for CCA

October 21st 2019

EP. 7: Frontline Therapy for CCA

October 21st 2019

EP. 8: Second-Line Therapy for CCA

October 21st 2019

EP. 9: Molecular Testing for CCA

October 21st 2019

EP. 10: Mutual Exclusivity in CCA

October 21st 2019

EP. 11: Infigratinib for CCA

October 21st 2019

EP. 12: FGFR Inhibitors in Development for CCA

October 21st 2019

EP. 13: Ivosidenib for Advanced IDH1-Mutated CCA

October 21st 2019

EP. 14: ClarIDHy Phase III Trial of Ivosidenib in CCA

October 21st 2019

EP. 15: Final Thoughts on CCA

October 21st 2019